Founded in 2016 in Hamburg, Germany, Apollo Ventures invests in companies that treat, prevent, or reverse diseases like Alzheimer's, heart disease, sarcopenia, frailty, and cancer. Their portfolio includes Aeovian Pharmaceuticals, Samsara Therapeutics, and Cleara Biotech. With a focus on accelerating breakthrough scientific discoveries, Apollo works with scientists and entrepreneurs to create new ventures and engages in hypothesis-driven company building. They have made four investments, with their most recent being a $37M investment in Aeovian Pharmaceuticals in October 2019.